drugset / Trial / NCT00267592
Safety and Efficacy of Talampanel in Glioblastoma Multiforme
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to estimate overall survival for adult patients with newly diagnosed glioblastoma multiforme treated with talampanel during radiation therapy with concurrent and adjuvant temozolomide. This study will also determine the toxicity and toxicity rate of talampanel for this therapeutic regimen.
Timeline
- Start
- 2005-12
- Primary completion
- 2008-09
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Talampanel | Small molecule | — | Oral |
| Background | Temozolomide | Small molecule | 200 mg | — |